Welcome - Register - Login - Help/FAQ - 0 items

Search Enter keywords, a title or a report id number below. In All Categories --------------------- Telecom & Computing Business & Finance Mfg & Construction Pharma & Healthcare Consumer & Retail Gov & Public Sector Energy & Transport Country Reports Company Reports --------------------- Transcripts Advanced      Select a currency for use throughout the site Australia Dollars Canada Dollars Euro Japan Yen Sweden Kroner Switzerland Francs UK Pounds US Dollars Search Results Your Search for 'South Korea Pharmaceuticals and Healthcare Report Q' returned 67 results - Page 1 of 4  FEATURED RESULTS The Top 100 European Manufacturers Of Finished Pharmaceuticals The Top 60 European Manufacturers Of Generic Pharmaceuticals Maven Semantic Healthcare Database (SME Package) The Top 60 European Manufacturers Of Generic Pharmaceuticals Radiopharmaceuticals - A US and European Market Analysis   Sort by    Date Published ASC Date Published DESC Report Price ASC Report Price DESC Rank ASC Rank DESC   Sorted by Rank Top-Bottom South Korea Pharmaceuticals and Healthcare Report Q1 2011   Business Monitor International, Nov 2010, Pages: 105 Pharmaceutical Company - Kuhnil Pharmaceutical - Choongwae - GlaxoSmithKline - Pfizer - Sanofi-Aventis - Merck & Co - Novartis - Eli Lilly South Korea Pharmaceuticals and Healthcare Report Q1 2011 South Korea Pharmaceuticals and Healthcare Report Q4 2010   Business Monitor International, Aug 2010 - Novartis - Eli Lilly South Korea Pharmaceuticals and Healthcare Report Q4 2010 South Korea Pharmaceuticals and Healthcare Report Q1 2012   Business Monitor International, Nov 2011, Pages: 106 -Pfizer -Sanofi-Aventis -Yuhan Corporation South Korea Pharmaceuticals and Healthcare Report Q1 2012 South Korea Pharmaceuticals and Healthcare Report Q4 2011   Business Monitor International, Aug 2011, Pages: 103 Pharmaceutical Co - Yuhan Corporation - Daewoong Pharmaceutical - Bukwang Pharmaceutical Company - Kuhnil Pharmaceutical - Choongwae South Korea Pharmaceuticals and Healthcare Report Q4 2011 South Korea Pharmaceuticals and Healthcare Report Q3 2011   Business Monitor International, May 2011, Pages: 103 South Korea Pharmaceuticals and Healthcare Report Q3 2011 South Korea Pharmaceuticals and Healthcare Report Q1 2010   Business Monitor International, Nov 2009, Pages: 96 - Daewoong Pharmaceutical - Bukwang Pharmaceutical Company - Kuhnil Pharmaceutical - Choongwae South Korea Pharmaceuticals and Healthcare Report Q1 2010 Pharmaceutical M&A in the Asia-Pacific Region - India and China drive regional activity but Japan still dominates high value transactions   Datamonitor, Aug 2010, Pages: 125 Singaporean market Government participation in healthcare Key health concerns Pharmaceutical market structure South Korea is relatively lucrative, but can be tricky to navigate Government participation Pharmaceutical Licensing and Alliances in the Asia-Pacific Region - Pharma enhances its focus on APAC markets   Datamonitor, Nov 2010, Pages: 162 of South Korea, China and India reported almost as many deals as Australia during Q3 2009 to Q2 2010. Features and benefits - Gain insight into the number and scope of deals and alliances in Asia-Pacific India Pharmaceuticals and Healthcare Report Q1 2011   Business Monitor International, Jan 2010, Pages: 98 - Granules India - Piramal Healthcare - Zydus Cadila - Pfizer - GlaxoSmithKline (GSK) - Novartis - Sanofi-Aventis - Merck & Co India Pharmaceuticals and Healthcare Report Q1 2011 Switzerland Pharmaceuticals and Healthcare Report Q1 2011   Business Monitor International, Dec 2010, Pages: 82 - Serono (Merck-Serono) Switzerland Pharmaceuticals and Healthcare Report Q1 2011 Switzerland Pharmaceuticals and Healthcare Report Q1 2011   Business Monitor International, Dec 2010, Pages: 82 - Merck-Serono Switzerland Pharmaceuticals and Healthcare Report Q1 2011 Switzerland Pharmaceuticals and Healthcare Report Q1 2011   Business Monitor International, Dec 2010, Pages: 82 , - Merck-Serono Switzerland Pharmaceuticals and Healthcare Report Q1 2011 Switzerland Pharmaceuticals and Healthcare Report Q1 2011   Business Monitor International, Dec 2010, Pages: 82 - Merck-Serono Switzerland Pharmaceuticals and Healthcare Report Q1 2011 Switzerland Pharmaceuticals and Healthcare Report Q1 2011   Business Monitor International, Dec 2010, Pages: 82 - Serono (Merck-Serono) Switzerland Pharmaceuticals and Healthcare Report Q1 2011 Switzerland Pharmaceuticals and Healthcare Report Q1 2011   Business Monitor International, Dec 2010, Pages: 82 - Merck-Serono Switzerland Pharmaceuticals and Healthcare Report Q1 2011 Australia Pharmaceuticals and Healthcare Report Q3 2010   Business Monitor International, May 2010, Pages: 90 with independent forecasts and competitive intelligence on Australia's pharmaceuticals and healthcare industry. Along with South Korea, Australia is the joint most attractive pharmaceutical market in Asia Pacific Australia Pharmaceuticals and Healthcare Report Q2 2011   Business Monitor International, Feb 2011, Pages: 87 (Hospira) - Sanofi-Aventis - GlaxoSmithKline - Merck & Co - Novartis Australia Pharmaceuticals and Healthcare Report Q2 2011 Spectrum Pharmaceuticals, Inc. (SPPI) - Financial and Strategic SWOT Analysis Review   GlobalData, Sep 2011, Pages: 44 and commercialization of Apaziquone in South Korea. The company has three subsidiaries namely OncoRx Pharma Private Limited, Spectrum Pharma Canada, RIT Oncology, LLC and Spectrum Pharmaceuticals GmbH. Spectrum Argentina Pharmaceuticals and Healthcare Report Q4 2010   Business Monitor International, Aug 2010, Pages: 89 - Laboratorios Roemmers - Laboratorios Bagó - Pfizer - Roche - Novartis - GlaxoSmithKline - Sanofi-Aventis - Merck & Co - Boehringer Ingelheim Argentina Pharmaceuticals and Healthcare Report Q4 2010 Australia Pharmaceuticals and Healthcare Report Q1 2010   Business Monitor International, Nov 2009, Pages: 94 Pharmaceuticals - Mayne Pharma (Hospira) - CSL Australia Pharmaceuticals and Healthcare Report Q1 2010 Results:  First -   Prev -   1 -   2 -   3 -   4 -   Next -   Last

		For enquiries please call us on:   +353-1-415-1241 (GMT Office Hours)   1-800-526-8630 (US/Canada Toll Free)   1-917-300-0470 (EST Office Hours)

All rights reserved. © Copyright 2012 Research and Markets3    Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network